Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 4
1992 1
1993 1
1994 1
1995 2
1997 3
1998 1
1999 4
2000 4
2001 2
2002 4
2003 3
2004 8
2005 7
2006 6
2007 7
2008 1
2010 3
2011 3
2012 3
2013 1
2016 1
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 16080557

65 results
Results by year
Filters applied: . Clear all
Page 1
An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.
Pectasides D, Kalofonos HP, Samantas E, Nicolaides C, Papacostas P, Onyenadum A, Visvikis A, Skarlos D, Fountzilas G. Pectasides D, et al. Anticancer Res. 2001 Jul-Aug;21(4B):3005-10. Anticancer Res. 2001. PMID: 11712802 Clinical Trial.
Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.
Lee DH, Han JY, Cho KH, Pyo HR, Kim HY, Yoon SJ, Lee JS. Lee DH, et al. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1037-44. doi: 10.1016/j.ijrobp.2005.04.034. Epub 2005 Jul 18. Int J Radiat Oncol Biol Phys. 2005. PMID: 16024178 Clinical Trial.
Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial.
Binder D, Schweisfurth H, Grah C, Schäper C, Temmesfeld-Wollbrück B, Siebert G, Suttorp N, Beinert T. Binder D, et al. Cancer Chemother Pharmacol. 2007 Jun;60(1):143-50. doi: 10.1007/s00280-006-0358-7. Epub 2006 Oct 10. Cancer Chemother Pharmacol. 2007. PMID: 17031643 Clinical Trial.
65 results